VIVORYON THERAPEUTICS N.V.

Transcripts Vivoryon Therapeutics N.V.

Equities

VVY

NL00150002Q7

Market Closed - Euronext Amsterdam Other stock markets 11:35:27 2024-04-26 am EDT			5-day change	1st Jan Change
0.8 ^EUR	-2.44%		+76.60%	-90.17%

Apr. 24	Transcript : Vivoryon Therapeutics N.V., 2023 Earnings Call, Apr 24, 2024
Mar. 15	Vivoryon Therapeutics N.V Announces Resignation of Board of Directors	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Vivoryon Therapeutics N.V., 2023 Earnings Call, Apr 24, 2024	Apr. 24
Transcript : Vivoryon Therapeutics N.V., Q3 2023 Earnings Call, Dec 06, 2023	Dec. 06
Transcript : Vivoryon Therapeutics N.V. - Special Call	23-10-17
Transcript : Vivoryon Therapeutics N.V., H1 2023 Earnings Call, Sep 07, 2023	23-09-07
Transcript : Vivoryon Therapeutics N.V., Q4 2022 Earnings Call, Apr 19, 2023	23-04-19
Transcript : Vivoryon Therapeutics N.V. Presents at Barclays Global Healthcare Conference, Mar-16-2023 08:00 AM	23-03-16
Transcript : Vivoryon Therapeutics N.V., Q3 2022 Earnings Call, Nov 22, 2022	22-11-22
Transcript : Vivoryon Therapeutics N.V., H1 2022 Earnings Call, Sep 30, 2022	22-09-30
Transcript : Vivoryon Therapeutics N.V. - Special Call	22-08-02
Transcript : Vivoryon Therapeutics N.V. - Shareholder/Analyst Call	22-06-22
Transcript : Vivoryon Therapeutics N.V., 2021 Earnings Call, Apr 28, 2022	22-04-28
Transcript : Vivoryon Therapeutics N.V., H1 2021 Earnings Call, Sep 21, 2021	21-09-21
Transcript : Vivoryon Therapeutics N.V., 2020 Earnings Call, Apr 30, 2021	21-04-30
Vivoryon Therapeutics N.V. Provides Earnings Guidance for the Year 2021	21-04-30	CI
Transcript : Vivoryon Therapeutics N.V. - Special Call	21-04-15
Transcript : Vivoryon Therapeutics AG, H1 2020 Earnings Call, Aug 27, 2020	20-08-27
Transcript : Vivoryon Therapeutics AG, 2019 Earnings Call, Mar 26, 2020	20-03-26
Probiodrug AG Announces Financial Results for the Year Ended 31 December 2017; Provides Financial Guidance for 2018	18-04-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer